1331755-58-8

Basic information

• Product Name: 1-[5-(tert-butyldiphenylsilyloxymethyl)-4-methyl-1-(2-(trimethylsilyl)ethoxymethyl)-1H-imidazol-2-yl]ethanone
• Synonyms: 1-[5-(tert-butyldiphenylsilyloxymethyl)-4-methyl-1-(2-(trimethylsilyl)ethoxymethyl)-1H-imidazol-2-yl]ethanone
• CAS NO: 1331755-58-8
• Molecular Weight: 522.835
• Mol File: 1331755-58-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 1-[5-(tert-butyldiphenylsilyloxymethyl)-4-methyl-1-(2-(trimethylsilyl)ethoxymethyl)-1H-imidazol-2-yl]ethanone(CAS DataBase Reference)
• NIST Chemistry Reference: 1-[5-(tert-butyldiphenylsilyloxymethyl)-4-methyl-1-(2-(trimethylsilyl)ethoxymethyl)-1H-imidazol-2-yl]ethanone(1331755-58-8)
• EPA Substance Registry System: 1-[5-(tert-butyldiphenylsilyloxymethyl)-4-methyl-1-(2-(trimethylsilyl)ethoxymethyl)-1H-imidazol-2-yl]ethanone(1331755-58-8)

Safety Data

• Hazardous Substances Data: 1331755-58-8(Hazardous Substances Data)

Upstream product

• 76513-69-4 (2-trimethylethylsilylethoxy)methyl chloride 
• 78191-00-1 N-Methoxy-N-methylacetamide 
• 38585-62-5 4-hydroxymethyl-5-methylimidazole hydrochloride 
• 58479-61-1 tert-butylchlorodiphenylsilane 

Relevant articles and documents

Imidazole Derivative

To provide a novel compound or an isotope thereof or a pharmaceutically acceptable salt thereof having S1P lyase inhibitory capacity and inducing the decrease in number of lymphocytes, and a pharmaceutical composition containing these as active ingredients. A compound represented by the general formula (I): or the general formula (II): or an isotope thereof or a pharmaceutically acceptable salt thereof.